Recruiting for Acute Myocardial Infarction Cell Therapy Trials

T he 21st century dawned with the promise of cell therapy for the treatment of cardiovascular disease. Beginning in 2002, with Orlic’s animal model work demonstrating the potential benefit of autologous cells on left ventricular (LV) function in animals,[1][1] additional work[2][2]–[4][3]